Literature DB >> 7418269

Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis.

H Repo, A M Jokipii, M Leirisalo, T U Kosunen.   

Abstract

Polymorphonuclear leucocytes (PMNs) of the newborn show poor movement in vitro toward a chemotactic stimulus, such as zymosan-activated human serum (ZAS). This may result from a defect either in spontaneous movement or in the response of the cells to the stimulus. To identify the defect we studied chemotaxis, chemokinesis and spontaneous movement of cord blood PMNs by agarose assay and by the leading front modification of the Boyden chamber technique. Under agarose, cord PMNs showed much spontaneous movement. This, associated with poor stimulated movement, indicated a defect in the responsiveness of cord PMNs to ZAS. In the membrane filter, cord PMNs migrated spontaneously, and in the presence of ZAS, significantly less than adult cells. The weak spontaneous movement most probably resulted from poor deformability of cord PMNs and contributed to the weak stimulated movement of these cells in the filter. Our results indicate that the impaired chemotaxis was due to a defect in both responsiveness and deformability of cord PMNs rather than to a defect in their intrinsic ability to move.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418269      PMCID: PMC1538952     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Chemotactic migration of neutrophils under agarose.

Authors:  T J John; O F Sieber
Journal:  Life Sci       Date:  1976-01-15       Impact factor: 5.037

3.  Cellular and humoral components of monocyte and neutrophil chemotaxis in cord blood.

Authors:  S G Pahwa; R Pahwa; E Grimes; E Smithwick
Journal:  Pediatr Res       Date:  1977-05       Impact factor: 3.756

4.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

5.  Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes.

Authors:  H Repo; A A Kostiala; T U Kosunen
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

6.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

7.  Lazy-leucocyte syndrome. A new disorder of neutrophil function.

Authors:  M E Miller; F A Oski; M B Harris
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

8.  Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. I. Effects of environmental factors on neutrophil migration under agarose.

Authors:  H Repo
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

9.  Distinct chemokinetic and chemotactic responses in neutrophil granulocytes.

Authors:  H U Keller; J H Wissler; M W Hess; H Cottier
Journal:  Eur J Immunol       Date:  1978-01       Impact factor: 5.532

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  11 in total

1.  The effects of anesthesia and surgery on count and function of neutrophils.

Authors:  Y Tabuchi; S Shinka; H Ishida
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

2.  Fluorescent staining of the actin cytoskeleton in human lymphocytes, monocytes and polymorphonuclear cells using a DNAse 1/anti-DNAse 1 immunoglobulin fluorescein conjugated system.

Authors:  P J Philip; I Sudaka; B Mely-Goubert
Journal:  Histochemistry       Date:  1992

3.  An increase in polymorphonuclear leucocyte chemotaxis accompanied by a change in the membrane fluidity with age during childhood.

Authors:  K Yasui; M Masuda; T Tsuno; T Matsuoka; A Komiyama; T Akabane; K Murata
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

4.  Alterations in complement-induced shape change and stimulus-specific superoxide anion generation by neonatal calf neutrophils.

Authors:  W Holden; D O Slauson; R D Zwahlen; M M Suyemoto; M Doré; N R Neilsen
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

5.  Phagocyte function in juvenile periodontitis.

Authors:  H Repo; L Saxén; M Jäättelä; M Ristola; M Leirisalo-Repo
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

6.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

7.  Chemotactic and random movement of cord-blood granulocytes.

Authors:  L Máródi; J Jezerniczky; S Csorba; L Karmazsin; P C Leijh; R van Furth
Journal:  Experientia       Date:  1984-12-15

8.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastases.

Authors:  R Markkula; H Repo; M Leirisalo; C Blomqvist; I Elomaa
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Alterations in neonatal neutrophil function attributable to increased immature forms.

Authors:  Marjorie Makoni; Jeffrey Eckert; H Anne Pereira; Victor Nizet; Shelley M Lawrence
Journal:  Early Hum Dev       Date:  2016-07-16       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.